Stigma Affects Quality of Life in Children With Chronic Skin Conditions
By Lori Solomon HealthDay Reporter
TUESDAY, April 30, 2024 -- Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.
Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the extent of stigma, dependence on disease visibility and severity, and association with mental health and quality of life (QOL) in chronic pediatric skin disease. The analysis included 1,671 children.
The researchers found that stigma scores significantly differed by level of physician-assessed and child/proxy-assessed disease visibility and severity. Only 27.0 percent of children with chronic acne, atopic dermatitis, alopecia areata, and vitiligo had T scores <40 (minimal or no stigma) and 43.8 percent had at least moderate stigma (T score ≥45) versus children with a range of chronic diseases. There was a strong correlation between stigma scores and reduced QOL, depression, anxiety, and poor peer relationships. More than one-fourth of parents (29.4 percent) were aware of bullying of their child, which was strongly associated with stigma. More stigma was reported by girls than boys.
"The findings of this study suggest that physician assessment of disease severity and visibility is insufficient to evaluate the disease impact in the patient/caregiver," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Health Status, Mental Health Worsened in U.S. Transgender Adults From 2014 to 2022
TUESDAY, June 25, 2024 -- Health status, mental health, and health inequities worsened in the United States from 2014 to 2022 among transgender (TGD) adults, according to a...
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus
TUESDAY, June 25, 2024 -- For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.